Search results
BridgeBio Announces Durable Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in...
Morningstar· 3 days ago- At Month 18, there was a statistically significant improvement in body proportionality (p-value of 0.001). PALO ALTO, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq ...
BridgeBio data show sustained benefit for achondroplasia drug
BioPharma Dive via Yahoo Finance· 3 days agoLonger follow-up results from a mid-stage trial indicate the company’s treatment for a genetic cause...
Hear from 6 plaintiffs on the Texas emergency abortion ruling
San Antonio Express-News· 6 days agoThe case was the most significant challenge to the state's abortion bans since they took effect in...
Texas Supreme Court rejects challenge to state abortion ban's medical exceptions
Fox News via Yahoo News· 6 days agoLast year, plaintiffs in the lawsuit testified in court how they carried babies they knew would not...
BridgeBio Pharma Shares One Year Data From Dwarfism Candidate - BridgeBio Pharma (NASDAQ:BBIO)
Benzinga· 3 days agoTuesday, BridgeBio Pharma Inc BBIO announced sustained results from the PROPEL 2 Phase 2 trial of...
Texas Supreme Court rejects challenge to abortion ban
KXAN via Yahoo News· 7 days agoThe court held that the medical exceptions in Texas' abortion ban are sufficiently broad, and do not...
State of Texas: ‘School choice’ plan poised to pass after runoff wins for Abbott-backed candidates
KXAN via Yahoo News· 5 days agoGov. Greg Abbott is declaring victory in his 18-month-long fight for a school choice initiative that...